HINOON against its peers Highnoon Laboratories Limited
Highnoon Laboratories Limited (HINOON) is set against 10 peers in the PHARMACEUTICALS sector. By market value it ranks 4 of 11.
PHARMACEUTICALS peers on one table
| Company | Last close (Rs) | Place in the 52-week range | Market value | Price per rupee earned (12 months) | Fund lines |
|---|---|---|---|---|---|
| GLAXO | 336.36 | 28% | Rs 107.1 bn | 9.75 | — |
| ABOT | 1,000.00 | 39% | Rs 97.9 bn | 10.54 | — |
| HALEON | 697.10 | 14% | Rs 81.6 bn | 12.52 | — |
| HINOON (this company) | 959.62 | 53% | Rs 50.8 bn | 12.36 | — |
| SEARL | 79.22 | 9% | Rs 46.6 bn | 11.98 | — |
| AGP | 156.37 | 10% | Rs 43.8 bn | 24.47 | — |
| HPL | 3,991.06 | 19% | Rs 38.5 bn | 11.01 | — |
| FEROZ | 362.49 | 40% | Rs 15.8 bn | 22.91 | 1 |
| CPHL | 63.42 | 15% | Rs 14.5 bn | 17.81 | — |
| MACTER | 263.98 | 30% | Rs 12.1 bn | 18.87 | — |
| BFBIO | 135.26 | 29% | Rs 11.9 bn | 18.18 | — |
Place in the range: 0% is the 52-week low and 100% the high, on closes adjusted for splits and bonus issues. The other companies are those in the same PSX sector that traded in the last 10 sessions. A sector median needs 1 or more companies. As of 13 Nov 2026.
Fund lines: the number of funds that list the company in the top ten of their latest monthly report. A blank means no report shows it, not that no fund owns it.
Returns against the index and the sector
HINOON return with dividends by window
| Window | HINOON price | HINOON with dividends | KSE-100 | Sector median |
|---|---|---|---|---|
| 1 month | +4.45% | +4.45% | +7.53% | +5.08%14 companies |
| 3 months | -4.38% | -4.38% | -1.24% | -4.39%14 companies |
| 6 months | +0.75% | +0.75% | +7.41% | -3.09%14 companies |
| Since 1 January | -6.15% | -1.26% | +2.19% | -18.41%14 companies |
| 1 year | -14.81% | -10.37% | +10.72% | -14.68%14 companies |
| 3 years | +113.14% | +139.79% | +213.90% | +176.25%13 companies |
| 5 years | +54.03% | +78.62% | +288.80% | +73.06%12 companies |
Price only: closes adjusted for bonus and rights issues, to the latest price. With dividends: adds cash dividends, not reinvested. The KSE-100 figure reinvests dividends. Source: PSX closes and payout notices.
More on HINOON
- HINOON share price and overview
- HINOON dividend history
- Pharmaceuticals sector
- HPL peers · Hoechst Pakistan Limited
- IBLHL peers · IBL HealthCare Limited
- LIVEN peers · Liven Pharma Limited
- GLAXO peers · GlaxoSmithKline Pakistan Limited
- ABOT peers · Abbott Laboratories (Pakistan) Limited
- HALEON peers · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .